Astria Therapeutics: Pipeline And Market Potential Post BioCryst Acquisition

Astria Therapeutics, Inc. (NASDAQ: ATXS ) isn't a stock that would be on everyone's radar before this week. It's a relatively small biotech with shares trading in the mid-$8 range. However, the stock has seen quite a bitI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation ...